Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

Novo Nordisk’s plummet is a warning for backers who’ve crowded into a relatively small group of very large stocks.

Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a ...

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

The overarching commonality is that there isn't one: "Not all people experiences the same degree of facial and body changes ...

The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, Wegovy®, and Mounjaro® has transformed obesity care and created an unexpected cosmetic challenge. Rapid fat loss can leave ...

While Ozempic is effective at treating type 2 diabetes and supporting weight loss, it can also come with side effects.

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

Peanuts instead of Panadol and a salad that can kill your appetite could be the results of a new Sydney research project.